Abbott Laboratories (ABT) Market Capitalization, Earnings, Price, Holders
Abbott Laboratories
Symbol: ABT Rank: #53 Price: $110.8(-0.85898%)

Market Cap: $192.5B($-1.6B) Industry: Medical Devices Sector: Healthcare Country: United States Insiders: 0.74% Institutions: 76.37%
Abbott Laboratories Technicals

52 Week High: $122.66

52 Week Low: $92.83

50 Day MA: $109

200 Day MA: $106.87

52 Week Trading Range


Low: $92.83

High: $122.66

Daily Trading Range


Low: $110.73

High: $111.45

Market capitalization history for Abbott Laboratories (ABT) in USD

As of November 2023, Abbott Laboratories (ABT) has a market cap of $192.5 billion. Our data points out that ABT is ranked #53 in the world. A company's market capitalization is the present value of all of its outstanding shares, and it is commonly used to give a sense of how much the stock of a company would be worth at today's exchange rates. ABT's market cap is -0.858983% down from the last trading day.

ABT Statistics

Market Cap
Revenue TTM
Gross Profit TTM
Operating Margin TTM
Shares Outstanding
Shares Float
Trading Volume
P/E Ratio
PEG Ratio
Revenue Per Share
Dividend Per Share
Dividend Yield
Quote Type
Leaf logo
CDP Climate Change Score (ABT)

Latest News

Abbott Laboratories (ABT) Shares Stats
Abbott Laboratories (ABT) Valuation
Trailing P/E $25.7864
Forward P/E $25.1256
Price Sales TTM $4.2019
Price Book MRQ $5.4377
Enterprise Value $200,497,018,429
Enterprise Value Revenue $4.4525
Enterprise Value Ebitda $15.1995
Abbott Laboratories Details

Address: 100 Abbott Park Road

City: North Chicago

Zip: 60064-6400

Phone: 224 667 6100


IPO Date: 1978-01-13

CEO: Robert B. Ford

Employees: 113,000

What is ABT about?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.